RecruitingNot ApplicableNCT05699018

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients

Sponsor

University Hospital, Angers

Enrollment

1,788 participants

Start Date

Mar 13, 2023

Study Type

INTERVENTIONAL

Conditions

Liver Fibrosis Non-alcoholic Fatty Liver Disease NAFLD Alcoholic Liver Disease (ALD)

Summary

The primary objective of the SOPRANO study is to compare two blood fibrosis tests, the eLIFT and the FibroMeter, for the screening of advanced liver fibrosis in patients with NAFLD and/or ALD from primary care centers.

Eligibility

Min Age: 40 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying eLIFT for people with alcoholic liver disease (ald), liver fibrosis, and other related conditions. The study is currently recruiting participants at 12 locations. People eligible for this study include aged 40 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTeLIFT

Diagnostic procedure: elastography devices, blood tests (e-LIFT + Fibrometer), liver biopsy if necessary (elastometry ≥ 8 kPa and \< 15 kPa)

Locations(13)

ANGERS

Angers, France

CHU Angers

Angers, France

BAUGE

Baugé-en-Anjou, France

BECON

Bécon-les-Granits, France

Chalonnes

Chalonnes-sur-Loire, France

COMBOURG

Combourg, France

LIFFRE

Liffré, France

Montreuil

Montreuil-Bellay, France

RENNES - Armagnac, Churchill

Rennes, France

RENNES - Kennedy

Rennes, France

CHU Rennes

Rennes, France

SEGRE

Segré, France

Val Couesnon

Val-couesnon, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05699018

Related Trials

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

NCT06632444525 locations

Taiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLD

NCT076924381 location

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

NCT0761083720 locations

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

NCT061388212 locations

Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme

NCT076587551 location